These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 19890272)
81. Klotho/FGF23 and Wnt in SHPT associated with CKD Wu Q; Fan W; Zhong X; Zhang L; Niu J; Gu Y Am J Transl Res; 2022; 14(2):876-887. PubMed ID: 35273691 [TBL] [Abstract][Full Text] [Related]
82. Deficiency of Soluble α-Klotho as an Independent Cause of Uremic Cardiomyopathy. Xie J; Wu YL; Huang CL Vitam Horm; 2016; 101():311-30. PubMed ID: 27125747 [TBL] [Abstract][Full Text] [Related]
83. Immunohistochemical study of fatty acid synthase, Ki67, proliferating cell nuclear antigen, and p53 expression in hyperplastic parathyroids. Alò PL; Visca P; Mazzaferro S; Serpieri DE; Mangoni A; Botti C; Monaco S; Carboni M; Zaraca F; Trombetta G; Di Tondo U Ann Diagn Pathol; 1999 Oct; 3(5):287-93. PubMed ID: 10556475 [TBL] [Abstract][Full Text] [Related]
84. Parathyroid resistance to FGF23 in kidney transplant recipients: back to the past or ahead to the future? Komaba H; Koizumi M; Fukagawa M Kidney Int; 2010 Nov; 78(10):953-5. PubMed ID: 21030971 [TBL] [Abstract][Full Text] [Related]
85. Activator protein 2alpha mediates parathyroid TGF-alpha self-induction in secondary hyperparathyroidism. Arcidiacono MV; Cozzolino M; Spiegel N; Tokumoto M; Yang J; Lu Y; Sato T; Lomonte C; Basile C; Slatopolsky E; Dusso AS J Am Soc Nephrol; 2008 Oct; 19(10):1919-28. PubMed ID: 18579641 [TBL] [Abstract][Full Text] [Related]
86. Expression of basic fibroblast growth factor in hyperplastic parathyroid glands from patients with multiple endocrine neoplasia type I. Komatsu M; Tsuchiya S; Matsuyama I; Kaneko S; Suzuki Y; Ito N; Hanamura N; Seki T; Kobayashi S; Kuroda T World J Surg; 1994; 18(6):921-4; discussion 925. PubMed ID: 7846920 [TBL] [Abstract][Full Text] [Related]
87. Single-cell RNA sequencing reveals transdifferentiation of parathyroid chief cells into oxyphil cells in patients with uremic secondary hyperparathyroidism. Mao J; You H; Wang M; Ba Y; Qian J; Cheng P; Lu C; Chen J Kidney Int; 2024 Mar; 105(3):562-581. PubMed ID: 38142040 [TBL] [Abstract][Full Text] [Related]
88. The role of calcium-sensing receptor abnormality in the pathogenesis of secondary hyperparathyroidism. Akizawa T; Ogata H; Koiwa F; Kinugasa E; Ideura T Nephrol Dial Transplant; 1999; 14 Suppl 1():66-7. PubMed ID: 10048456 [No Abstract] [Full Text] [Related]
89. Klotho is upregulated in human cardiomyopathy independently of circulating Klotho levels. Poelzl G; Ghadge SK; Messner M; Haubner B; Wuertinger P; Griesmacher A; Doerler J; Ensinger C; Ulmer H; Zaruba MM Sci Rep; 2018 May; 8(1):8429. PubMed ID: 29849175 [TBL] [Abstract][Full Text] [Related]
90. The parathyroid-bone axis in uremia: new insights into old questions. Hory B; Drüeke TB Curr Opin Nephrol Hypertens; 1997 Jan; 6(1):40-8. PubMed ID: 9051353 [TBL] [Abstract][Full Text] [Related]
91. A translocation causing increased alpha-klotho level results in hypophosphatemic rickets and hyperparathyroidism. Brownstein CA; Adler F; Nelson-Williams C; Iijima J; Li P; Imura A; Nabeshima Y; Reyes-Mugica M; Carpenter TO; Lifton RP Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3455-60. PubMed ID: 18308935 [TBL] [Abstract][Full Text] [Related]
92. Fibroblast growth factors and their receptors in parathyroid disease. Lambert D; Eaton CL; Harrison BJ World J Surg; 1998 Jun; 22(6):520-5. PubMed ID: 9597922 [TBL] [Abstract][Full Text] [Related]
93. Fibroblast growth factor receptor 1 (FGFR1) expression in phosphaturic mesenchymal tumors. Tajima S; Fukayama M Int J Clin Exp Pathol; 2015; 8(8):9422-7. PubMed ID: 26464698 [TBL] [Abstract][Full Text] [Related]
94. Identification of key biomarkers based on the proliferation of secondary hyperparathyroidism by bioinformatics analysis and machine learning. Shen A; Shi J; Wang Y; Zhang Q; Chen J PeerJ; 2023; 11():e15633. PubMed ID: 37456892 [TBL] [Abstract][Full Text] [Related]
95. Implications of regulator of G-protein signaling 5 expression in the pathogenesis of primary and secondary hyperparathyroidism. Li X; Lu Y; Zhang L; Song A; Zhang H; Pang B; Liu J; Sun X; Ji H; Huang L; Yang M BMC Endocr Disord; 2022 Jun; 22(1):156. PubMed ID: 35681135 [TBL] [Abstract][Full Text] [Related]
96. Frequent overexpression of klotho in fusion-negative phosphaturic mesenchymal tumors with tumorigenic implications. Lee CH; Su SY; Sittampalam K; Chen PC; Petersson F; Kao YC; Carpenter TO; Hsieh TH; Konishi E; Tsai JW; Billings SD; Folpe AL; Lee JC Mod Pathol; 2020 May; 33(5):858-870. PubMed ID: 31792355 [TBL] [Abstract][Full Text] [Related]
97. Expression of FGF-23 and FGFR1 is increased in uremic rat skin. Tulay Koz S; Ozkaynak O; Koz S; Aydin H; Goze OF Clin Nephrol; 2023 Sep; 100(3):107-114. PubMed ID: 37485880 [TBL] [Abstract][Full Text] [Related]
98. The vascular secret of Klotho. Lewin E; Olgaard K Kidney Int; 2015 Jun; 87(6):1089-91. PubMed ID: 26024025 [TBL] [Abstract][Full Text] [Related]
99. Accumulation of allelic changes at chromosomes 7p, 18q, and 2 in parathyroid lesions of uremic patients. Nagy A; Chudek J; Kovacs G Lab Invest; 2001 Apr; 81(4):527-33. PubMed ID: 11304572 [TBL] [Abstract][Full Text] [Related]